Stay updated with breaking news from Nasdaq Tcon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report) shares are set to reverse split on Wednesday, April 10th. The 1-20 reverse split was announced on Wednesday, April 10th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, April 10th. TRACON Pharmaceuticals Trading Down 24.8 % Shares of TCON traded […]
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report)’s stock is going to reverse split before the market opens on Wednesday, April 10th. The 1-20 reverse split was announced on Wednesday, April 10th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, April 10th. TRACON Pharmaceuticals Price Performance NASDAQ TCON […]
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a...
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report) – Research analysts at HC Wainwright reduced their FY2025 earnings per share estimates for shares of TRACON Pharmaceuticals in a report released on Wednesday, April 3rd. HC Wainwright analyst E. White now expects that the biopharmaceutical company will earn ($0.27) per share for the year, down from their […]
StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note released on Sunday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, HC Wainwright cut their price objective on TRACON Pharmaceuticals from $7.00 to $6.00 and set a buy rating for the company in a […]